SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,540.83 3.11
( 0.00%)

Global Indices

Nasdaq

52,797.06 -686.99
(-1.28%)

Dow Jones

7,662.83 -66.15
(-0.86%)

Hang Seng

65,893.13 -323.66
(-0.49%)

Nikkei 225

10,809.01 60.85
(0.57%)

Forex

USD-INR

95.63 -0.07
(-0.07%)

EUR-INR

111.19 0.41
(0.37%)

GBP-INR

129.81 0.28
(0.22%)

JPY-INR

0.60 0.00
(0.43%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Lupin Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500257

INE326A01037

659.0470742

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LUPIN

15.21

100732.9

EPS(TTM)

Face Value()

Div & Yield %

144.82

0.82

Back

tulive developers ltd

CCL Products (India) consolidated net profit rises 61.33% in the June 2026 quarter

Jul 28,2026

Net profit of CCL Products (India) rose 61.33% to Rs 116.88 crore in the quarter ended June 2026 as against Rs 72.45 crore during the previous quarter ended June 2025. Sales rose 13.72% to Rs 1200.45 crore in the quarter ended June 2026 as against Rs 1055.64 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1200.45	1055.64	14
OPM %	16.12	15.06	-
PBDT	168.03	127.74	32
PBT	129.02	94.19	37
NP	116.88	72.45	61

77,540.83 3.11 ( 0.00%)

52,797.06 -686.99 (-1.28%)

7,662.83 -66.15 (-0.86%)

65,893.13 -323.66 (-0.49%)

10,809.01 60.85 (0.57%)

95.63 -0.07 (-0.07%)

111.19 0.41 (0.37%)

129.81 0.28 (0.22%)

0.60 0.00 (0.43%)